Which hedge funds own AIMT? AIMMUNE THERAPEUTICS INC, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in AIMT (AIMMUNE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $0 in total.
- 0
- Holders
- 0
- New this quarter
- 0
- Exited this quarter
- $0
- Combined value
- –
- Share of managers holding
Holders, Q2 2026
Ownership over time
By quarter
| Quarter | Holders | Managers filing | Share holding | Combined value |
|---|---|---|---|---|
| Q4 2020 | 0 | 71 | 0.0% | $0 |
| Q3 2020 | 2 | 68 | 2.9% | $120m |
| Q2 2020 | 1 | 68 | 1.5% | $12.9m |
| Q1 2020 | 3 | 68 | 4.4% | $29.7m |
| Q4 2019 | 0 | 67 | 0.0% | $0 |
| Q3 2019 | 2 | 60 | 3.3% | $13.2m |
| Q2 2019 | 1 | 60 | 1.7% | $10.8m |
| Q1 2019 | 0 | 60 | 0.0% | $0 |
| Q4 2018 | 1 | 60 | 1.7% | $14.7m |
| Q3 2018 | 2 | 59 | 3.4% | $11.2m |
| Q2 2018 | 2 | 59 | 3.4% | $47.0m |
| Q1 2018 | 1 | 59 | 1.7% | $34.4m |
| Q4 2017 | 2 | 59 | 3.4% | $47.2m |
| Q3 2017 | 2 | 56 | 3.6% | $27.6m |
| Q2 2017 | 1 | 56 | 1.8% | $20.5m |
| Q1 2017 | 1 | 56 | 1.8% | $14.8m |
| Q4 2016 | 3 | 56 | 5.4% | $24.3m |
| Q3 2016 | 1 | 52 | 1.9% | $19.4m |
| Q2 2016 | 2 | 52 | 3.8% | $14.1m |
| Q1 2016 | 1 | 52 | 1.9% | $17.5m |
| Q4 2015 | 1 | 52 | 1.9% | $14.6m |
| Q3 2015 | 1 | 52 | 1.9% | $20.0m |
Who discovered AIMT first?
Earliest meaningful positions among the 6 tracked managers seen opening AIMT since Q3 2015.
| RA Capital Management, L.P. | Q3 2015 | 2.9% | Exited by Q1 2017 | −19% |
Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.